Pulse Biosciences Inc (PLSE)
6.86
+0.01
(+0.15%)
USD |
NASDAQ |
Apr 23, 16:00
7.01
+0.15
(+2.19%)
Pre-Market: 08:28
Pulse Biosciences Cash from Operations (TTM): -33.04M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -33.04M |
September 30, 2023 | -34.22M |
June 30, 2023 | -34.37M |
March 31, 2023 | -37.99M |
December 31, 2022 | -47.01M |
September 30, 2022 | -51.74M |
June 30, 2022 | -54.46M |
March 31, 2022 | -58.00M |
December 31, 2021 | -54.10M |
September 30, 2021 | -50.66M |
June 30, 2021 | -45.86M |
March 31, 2021 | -37.43M |
December 31, 2020 | -35.36M |
September 30, 2020 | -35.31M |
June 30, 2020 | -34.72M |
March 31, 2020 | -36.48M |
December 31, 2019 | -34.18M |
Date | Value |
---|---|
September 30, 2019 | -31.30M |
June 30, 2019 | -30.18M |
March 31, 2019 | -26.21M |
December 31, 2018 | -23.90M |
September 30, 2018 | -21.55M |
June 30, 2018 | -18.12M |
March 31, 2018 | -13.61M |
December 31, 2017 | -11.09M |
September 30, 2017 | -9.442M |
June 30, 2017 | -8.007M |
March 31, 2017 | -9.088M |
December 31, 2016 | -8.051M |
September 30, 2016 | -7.063M |
June 30, 2016 | -6.029M |
March 31, 2016 | -4.322M |
December 31, 2015 | -3.317M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-58.00M
Minimum
Mar 2022
-30.18M
Maximum
Jun 2019
-40.86M
Average
-36.48M
Median
Mar 2020
Cash from Operations (TTM) Benchmarks
Align Technology Inc | 785.78M |
ThermoGenesis Holdings Inc | -3.721M |
NeuroOne Medical Technologies Corp | -13.20M |
SINTX Technologies Inc | -14.12M |
Nutriband Inc | -3.623M |